Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Symptomless Dysphagia

Symptomless dysphasia is one of the main causes of pneumonia in elderly people with stroke, and swallowing or the cough reflex can prevent aspiration pneumonia.1 The article by Nakayama and colleagues (May 1998),2 concerning angiotensin-converting enzyme (ACE) inhibitors and the swallowing reflex, was a fascinating and timely study. We previously reported that ACE inhibitors may cure symptomles...

متن کامل

Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.

Symptomless dysphasia is one of the main causes of pneumonia in elderly people with stroke, and swallowing or the cough reflex can prevent aspiration pneumonia.1 The article by Nakayama and colleagues (May 1998),2 concerning angiotensin-converting enzyme (ACE) inhibitors and the swallowing reflex, was a fascinating and timely study. We previously reported that ACE inhibitors may cure symptomles...

متن کامل

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis.

Myocarditis is a disease whose pathogenesis is not completely understood and whose prevalence is likely underestimated. Individuals afflicted with this condition may be treated with agents that relieve symptoms arising from inflammation and concurrent cellular damage. One class of drugs commonly used in the treatment of myocarditis includes the angiotensin converting enzyme inhibitors, such as ...

متن کامل

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Blockade of the renin-angiotensin system* (RAS) with ACE inhibitors or angiotensin II type 1 receptor (AT1R) antagonists has become one of the most successful therapeutic approaches in medicine. Within 25 years, substantial evidence has accumulated to indicate that this therapy reduces blood pressure (BP),1 left ventricular (LV) mass,2 and proteinuria.3 RAS blockade results in a decrease in car...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Kidney International

سال: 2003

ISSN: 0085-2538

DOI: 10.1046/j.1523-1755.63.s83.16.x